ENHANCE: Cigarette Smoking Among Young Adults

Sponsor
University of Oklahoma (Other)
Overall Status
Recruiting
CT.gov ID
NCT04340947
Collaborator
(none)
132
1
2
18.9
7

Study Details

Study Description

Brief Summary

This study will examine perceptions and smoking behavior of menthol and non-menthol very low nicotine cigarettes in young adult smokers. The aims are to examine perceptions and smoking behavior in the laboratory and in the natural environment. A separate sub-sample of men and women who identify as LGBTQ2S+ will also be recruited.

Condition or Disease Intervention/Treatment Phase
  • Other: Very low nicotine cigarettes
N/A

Detailed Description

This proposal includes three different aspects of assessment for menthol smoking young adults. The laboratory phase includes three separate sessions of laboratory smoking through a machine designed to measure puff behavior; the EMA phase includes 21 days of monitoring smoking behavior and attitudes related to smoking when smoking one's usual brand cigarette, the assigned menthol low nicotine cigarette, and the assigned non-menthol low nicotine cigarette in the participant's natural environment. The order of administration of smoking menthol and non-menthol VLNC will be counterbalanced. There will be a 7-day wash-out period between each 7-day period of using low nicotine cigarettes. The final phase includes a virtual marketplace where participants can purchase and use the research cigarettes in the context of other available tobacco products on the market, or purchase no tobacco products at all. There will be a final assessment, over the phone or in-person, 30-days after the final study visit (at week 8), to assess tobacco use behavior and attitudes about tobacco use. Participants will be enrolled for approximately 9 weeks. Week 1 will consist of smoking one's usual brand of cigarette in the laboratory and then in their home environment for 7-days. Week 2 will consist of smoking the first very low nicotine cigarette in the home environment for 7 days and then in the laboratory. Week three will consist of a 7-day wash-out period where participants can smoke their usual brand again, as they normally would. Week 4 will consist of smoking the second very low nicotine cigarette at home for 7 days and then in the laboratory. Week 5 will consist of returning to the laboratory for a final study visit and complete a hypothetical experimental tobacco marketplace. One month (4 weeks) after the final study visit (week 9), participants will complete a 30-day follow-up of cigarette smoking and other tobacco use behavior.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
132 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Impact of a Reduced Nicotine Standard on Young Adult Appeal for Menthol and Non-menthol Cigarettes
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Menthol very low nicotine cigarette

Participants will smoke menthol flavored very low nicotine cigarettes in their home environment for 7 days. At the end of 7-days, they will also smoke one menthol flavored very low nicotine cigarette in the laboratory.

Other: Very low nicotine cigarettes
Participants will be randomized to smoke menthol and non-menthol flavored very low nicotine cigarettes in their home environment for 7 days and in the laboratory

Other: Non-menthol very low nicotine cigarette

Participants will smoke non-menthol flavored very low nicotine cigarettes in their home environment for 7 days. At the end of 7-days, they will also smoke one non-menthol flavored very low nicotine cigarette in the laboratory.

Other: Very low nicotine cigarettes
Participants will be randomized to smoke menthol and non-menthol flavored very low nicotine cigarettes in their home environment for 7 days and in the laboratory

Outcome Measures

Primary Outcome Measures

  1. Change in puff topography [Baseline to week 4]

    total inhalation volume from smoking behavior in the laboratory

  2. Change in Cigarette Evaluation Scale (CES) [Baseline to week 9]

    Subjective response to smoking

  3. Hypothetical Purchasing of Tobacco Products [Assessed during tobacco purchase tasks completed at week 5]

    Purchasing of cigarettes and other tobacco products across changing prices in Experimental Tobacco Marketplace task

Secondary Outcome Measures

  1. Change in CO boost [Baseline to week 4]

    measures expired alveolar carbon monoxide level

Other Outcome Measures

  1. Drop-out rate [From baseline (Visit 1) to week 9]

    Measure of compliance

  2. Minnesota Nicotine Withdrawal Scale (MNWS) [Baseline to week 9]

    Measures withdrawal symptoms

  3. Questionnaire of Smoking Urges (QSU) [Baseline to week 9]

    Measures craving

  4. Positive and Negative Affect Scale (PANAS) [Baseline to week 4]

    Measures affect

  5. Perceived Health Risk Scale [Baseline to week 8]

    Measures perceptions of risk of smoking

  6. Heart rate [Baseline to week 4]

    Measures cardiovascular function

  7. Blood pressure [Baseline to week 4]

    Measures cardiovascular function assessed through both systolic and diastolic pressures

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 26 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Ages18 to 26;

  2. Smoke cigarettes "somedays" or "everyday" for at least the past 3-months;

  3. A strong preference for menthol cigarettes (i.e., smoke menthol >80% of the time); and

  4. Ability to read English at an 8th grade level or higher;

  5. No immediate plans to quit smoking.

Exclusion Criteria:
  1. Current use of nicotine replacement therapy (NRT);

  2. Pregnant or planning to become pregnant, or currently breastfeeding;

  3. Past or current self-reported clinically significant heart disease or hypertension, or other smoking-related disease (by history) that preclude successful study completion;

  4. Serious psychiatric disorder;

  5. Inability to abstain from nicotine/tobacco products;

  6. Strong preference for non-menthol cigarettes (smoke non-menthol > 80% of the time)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Health Promotion Research Center Oklahoma City Oklahoma United States 73104

Sponsors and Collaborators

  • University of Oklahoma

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Oklahoma
ClinicalTrials.gov Identifier:
NCT04340947
Other Study ID Numbers:
  • ENHANCE
First Posted:
Apr 10, 2020
Last Update Posted:
Apr 12, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 12, 2022